Jonathan Sugimoto

Epidemiologist and Investigator





Lee EC, Chao DL, Lemaitre JC, Matrajt L, Pasetto D, Perez-Saez J, Finger F, Rinaldo A, Sugimoto JD, Halloran ME, Longini IM Jr., Ternier R, Vissieres K, Azman AS, Lessler J, Ivers LC. (2020). Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study. The Lancet. Global health, 8(8)

Niang MN, Sugimoto JD, Diallo A, Diarra B, Ortiz JR, Lewis KDC, Lafond KE, Halloran ME, Widdowson MA, Neuzil KM, Victor JC. (2020). Estimates of inactivated influenza vaccine effectiveness among children in Senegal: results from two consecutive cluster-randomized controlled trials in 2010 and 2011. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Diallo A, Diop OM, Diop D, Niang MN, Sugimoto JD, Ortiz JR, Faye EHA, Diarra B, Goudiaby D, Lewis KDC, Emery SL, Zangeneh SZ, Lafond KE, Sokhna C, Halloran ME, Widdowson MA, Neuzil KM, Victor JC. (2019). Effectiveness of Seasonal Influenza Vaccination in Children in Senegal During a Year of Vaccine Mismatch: A Cluster-randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69(10)

Tsang TK, Ghebremariam SL, Gresh L, Gordon A, Halloran ME, Katzelnick LC, Rojas DP, Kuan G, Balmaseda A, Sugimoto J, Harris E, Longini IM Jr., Yang Y. (2019). Effects of infection history on dengue virus infection and pathogenicity. Nature communications, 10(1)

Schwartz LM, Zaman K, Yunus M, Basunia AH, Faruque ASG, Ahmed T, Rahman M, Sugimoto JD, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC. (2019). Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69(12)

Potter GE, Wong J, Sugimoto J, Diallo A, Victor JC, Neuzil K, Halloran ME. (2019). Networks of face-to-face social contacts in Niakhar, Senegal. PLoS One, 14(8)

Ngwa MC, Liang S, Kracalik IT, Morris L, Blackburn JK, Mbam LM, Ba Pouth SF, Teboh A, Yang Y, Arabi M, Sugimoto JD, Morris JG Jr.. (2016). Cholera in Cameroon, 2000-2012: Spatial and Temporal Analysis at the Operational (Health District) and Sub Climate Levels. PLoS neglected tropical diseases, 10(11)

Lednicky JA, Iovine NM, Brew J, Loeb JC, Sugimoto JD, Rand KH, Morris JG Jr.. (2016). Hemagglutinin Gene Clade 3C.2a Influenza A(H3N2) Viruses, Alachua County, Florida, USA, 2014-15. Emerging infectious diseases, 22(1)

Tran CH, Sugimoto JD, Pulliam JR, Ryan KA, Myers PD, Castleman JB, Doty R, Johnson J, Stringfellow J, Kovacevich N, Brew J, Cheung LL, Caron B, Lipori G, Harle CA, Alexander C, Yang Y, Longini IM Jr., Halloran ME, Morris JG Jr., Small PA Jr.. (2014). School-located influenza vaccination reduces community risk for influenza and influenza-like illness emergency care visits. PloS one, 9(12)

Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, Calderwood SB, Harris JB, Longini IM Jr.. (2014). Household Transmission of Vibrio cholerae in Bangladesh. PLoS neglected tropical diseases, 8(11)

Chao DL, Matrajt L, Basta NE, Sugimoto JD, Dean B, Bagwell DA, Oiulfstad B, Halloran ME, Longini IM Jr.. (2011). Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. American journal of epidemiology, 173(10)

Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM Jr.. (2009). The transmissibility and control of pandemic influenza A (H1N1) virus. Science (New York, N.Y.), 326(5953)

Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr., Dye C, Halloran ME. (2009). Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences of the United States of America, 106(33)

Yang Y, Halloran ME, Sugimoto JD, Longini IM Jr.. (2007). Detecting human-to-human transmission of avian influenza A (H5N1). Emerging infectious diseases, 13(9)

If you’d like to update your profile, please email modifications to

This profile will be completed as soon as the Coordination Center receives more information from this member.
This site is registered on as a development site.